FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Former Virginia assistant principal on trial after allegedly ignoring warnings before 6-year-old shot teacher

What the Data Actually Says About Abortion and Women’s Health

California’s New Congressional Maps Favoring Dems Could Be Struck Down by the Supreme Court: Report

Oct. 7 Exhibit Sign in London Removed After Police Warn It Could Attract Terrorists

Breaking: OJ Simpson Witness and LAPD Detective Mark Fuhrman Dead at 74

Report: Immigrants Are Voluntarily Leaving US in Record Numbers Under Trump

DC Bar lawyer withdraws from Ed Martin disciplinary case after partisan posts surface

Hegseth unleashes on Massie in GOP primary showdown against Trump-backed Navy SEAL vet

The New Democrats: MI Dem Blasted for Campaigning with Twerking Videos, Own Mugshots

Austin shooting suspect named, timeline of terror revealed after teens’ alleged 28-hour, 12-attack rampage

Mark Fuhrman, detective at center of OJ Simpson murder trial, dead at 74

Senate Republicans confirm nearly 50 of Trump’s picks for energy, land management

Alabama boy battling cancer lands experimental drug after posting secret viral video that drew Trump response

WATCH: Mamdani bashed for going ‘full deranged marxist’ with rip on famous Ronald Reagan line

Breaking: 2 Shooters at California Islamic Center Neutralized – Multiple Causalities Confirmed

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”